Stem cell research in the United States faces limitations established in 2001, focusing on: derivation processes initiated before August 9, 2001; stem cells originating from embryos created for reproductive purposes and no longer needed; and informed consent obtained without financial incentives.
However, other countries have seen significant success with stem cell therapies. In Mexico, China, and India, stem cell therapy has been used to treat chronic conditions like heart disease, Parkinson’s disease, rheumatoid arthritis, autism, diabetes, multiple sclerosis, lupus, stroke, and spinal cord injuries. Furthermore, extensive research abroad explores stem cells as an alternative cancer treatment.
Canada utilizes stem cell therapy to repair damaged tendons and ligaments in high-performance racehorses. Stem cells extracted from the horse’s bone marrow are isolated, expanded in a lab, and re-injected at the injury site using ultrasound technology. This application holds considerable promise for human medicine.
The Biogenetics Institute in Mexico derives stem cells from umbilical cord blood, culturing them with specific growth factors and nutrients based on treatment needs. Their medical team includes physicians and health professionals from various fields, dedicated to assisting patients and families managing chronic illnesses.